Pulmonary Arterial Hypertension

Disease State Hub

Commentary

Review

Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Management

04/14/2022

Pulmonary arterial hypertension is a rare disorder in which there is high blood pressure in the arteries that bring blood from the right side of the heart to the lungs, usually with idiopathic origins....

04/14/2022

Research Summaries

FDA ALERT

FDA Approves First Activin Signaling Inhibitor Therapy in Patients With PAH

04/12/2024

Jessica Bard

The FDA has approved sotatercept-csrk, the first activin signaling inhibitor therapy, for the management of patients with pulmonary arterial hypertension (PAH). Based on the Phase 3 STELLAR trial,...

04/12/2024

conference coverage

conference coverage

PAH, CTEPH Diagnosis and Treatment Updates for Primary Care

09/27/2023

Martha Kingman, FNP-C, DNP, and Bradley A. Maron, MD, review the latest guidelines and best practices for the primary care provider in the diagnosis and management of pulmonary arterial hypertension and...

09/27/2023

mortality

Echocardiographic Pulmonary Arterial Capacitance Predicts PH Mortality

12/17/2020

Pulmonary arterial capacitance is a strong predictor of clinical outcomes for patients with pulmonary hypertension. The researchers assessed whether an echocardiographic surrogate for pulmonary arterial...

12/17/2020

Risk Management

Discrimination Ability of PAH Risk Scores Drops in Intermediate-Risk Populations

11/25/2020

In a new systematic review, researchers aimed to summarize the current data on risk prognostic models and scores for pulmonary arterial hypertension.

11/25/2020

Hypertension

Smoking Impacts Kidney Function in Arterial Hypertension

11/24/2020

In a recent study, researchers sought to examine the relationship between smoking, nutritional status, and renal function in patients with arterial hypertension.

11/24/2020

October 2024

Current Issue

October 2024

Volume 64

Issue 9